Key Finding
Electroacupuncture produced significantly greater reductions in Kupperman Index scores and hot flush frequency compared to sham acupuncture, while performing comparably to hormone therapy in overall symptom relief, suggesting its benefits extend beyond placebo.
If you're navigating the uncomfortable symptoms of perimenopause — hot flashes, mood changes, sleep disruption — you may be wondering whether there are alternatives to hormone therapy. A new scientific review offers encouraging news about electroacupuncture, a form of acupuncture that uses gentle electrical stimulation through the needles.
Researchers analyzed 12 clinical trials involving 746 women to evaluate how well electroacupuncture (EA) works for perimenopausal syndrome. They compared EA against hormone therapy (HT), sham (fake) acupuncture, and traditional manual acupuncture.
Here's what they found: Electroacupuncture performed just as well as hormone therapy across most measures, including overall symptom relief and hormone levels like FSH and LH. Women receiving EA did show lower estrogen (estradiol) levels compared to those on HT, which is expected since HT directly supplements estrogen.
When compared to sham acupuncture — where needles are placed incorrectly to act as a placebo — real electroacupuncture produced significantly better results in reducing overall symptom severity and hot flash frequency. This is important because it suggests electroacupuncture's benefits go beyond a simple placebo effect.
Electroacupuncture also showed a slight advantage over traditional manual acupuncture in reducing overall symptom scores. The research also hinted that women in the pre-menopausal transition phase may benefit more than those who are fully post-menopausal.
The researchers are cautious about drawing firm conclusions because the studies were relatively small and varied in quality. They call for larger, higher-quality trials to confirm these findings.
Still, for women seeking a non-hormonal option to manage perimenopausal symptoms, electroacupuncture appears to be a promising, well-tolerated choice. To explore whether electroacupuncture is right for you, consider consulting a licensed acupuncturist with experience in women's health and hormonal conditions.
This systematic review and meta-analysis (12 RCTs, n = 746) evaluated electroacupuncture (EA) for perimenopausal syndrome (PMS), comparing EA against hormone therapy (HT), sham EA, and manual acupuncture (MA). EA demonstrated comparable efficacy to HT on effective rate (RR = 0.98, 95% CI: 0.93–1.04), Kupperman Index (KI), and serum FSH and LH levels. Serum estradiol was significantly lower in EA versus HT groups (MD = −60.58), consistent with the pharmacological mechanism of HT. Critically, EA produced statistically significant reductions in KI (MD = −4.71) and hot flush score/24h (MD = −2.43) versus sham EA, supporting specific physiological effects beyond placebo. EA showed marginal superiority over MA on KI (MD = −2.44). Subgroup analysis suggested greater benefit in perimenopausal versus post-menopausal patients. Limitations include small sample sizes, heterogeneity, and risk of bias. EA represents a clinically relevant, low-risk adjunct or alternative to HT for perimenopausal symptom management pending larger confirmatory trials.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Breast cancer patients who received preoperative auricular electroacupuncture for three days before surgery had significantly lower anxiety, better sleep, higher postoperative recovery quality scores, and reduced NSAID use compared to sham controls.
📌 Intraoperative electroacupuncture at PC6 and PC4 significantly reduced the incidence of slow flow/no-reflow during PCI for acute myocardial infarction from 26.7% in controls to 6.7% in the treated group (RR 0.2; P=.04).
📌 Perioperative TEAS at LI4, PC6, ST36, and SP6 significantly reduced postoperative fatigue syndrome incidence and fatigue scores in elderly patients undergoing laparoscopic radical gastrectomy, alongside lower pain scores, reduced opioid consumption, and favorable anti-inflammatory and antioxidant biomarker changes.